2018 annual financial data
Compass Therapeutics 2018 Operating cash flow
Direct answer
Operating cash flow was -33,679,000 USD.
Operating income was -38,312,000 USD and net income was -38,286,000 USD.
Operating cash flow was -33,679,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -38,312,000 USD
- Net income
- -38,286,000 USD
- Operating cash flow
- -33,679,000 USD